Intranasal steroid use and COVID-19 mortality among asthma and COPD patients: A retrospective cohort study.

Dr Virginia Hernandez Santiago, Dr Adeniyi Francis Fagbamigbe,Prof Frank Sullivan,Dr Utkarsh Agrawal,Dr Daniel Morales,Prof Colin McCowan,Prof Brian Lipworth

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology（2023）

Cited 0|Views2

No score

Abstract

The role of INCS in COVID-19 is still unclear, but exposure to INCS does not adversely affect COVID-19 mortality. Further studies are needed to explore the association between their use and inflammatory activation, viral load, ACE2 gene expression, and outcomes, exploring different types and doses of INCS.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined